Skip to content
Acoerela logo β€” Driving Innovation in Optical Probes for Research and Clinic...

Acoerela

Driving Innovation in Optical Probes for Research and Clinical Diagnostics 🌈

Founded 2022 Singapore Singapore 7 employees Biotechnology, Life Sciences

General Information

Company Name Acoerela
Founded Year 2022
Location Singapore Singapore
Employees 7
Industries Biotechnology, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with Acoerela. To contact Acoerela, visit acoerela.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Acoerela compare?

A PDF of Acoerela and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Acoerela soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Acoerela

Acoerela is a Singapore-based startup driving chemical innovation in optical probes for research and clinical diagnostics. With a focus on biotechnology and life sciences, the company develops fluorescent dyes through innovative chemistry to advance the fields of life science research and clinical diagnostics. Established in 2022, Acoerela aims to revolutionize the industry through its groundbreaking approach to chemical innovation. As of now, the startup has not disclosed its last investment details or investors, signaling potential opportunities for venture capitalists to engage with this promising new player in the biotechnology and life sciences sector.

Business keywords: fluorescent dyes, chemistry, life science research, clinical diagnostics, optical probes, extracellular vesicles, exosomes, lipid nanoparticles, chemical innovation

No funding data available for Acoerela yet.

Acoerela Alternatives & Competitors

View All Alternatives
Acoerela vs

Your Health. Our Promise.

210 employees
Biopharma, Biotechnology
Acoerela vs

MEDHOM is an innovative company that follows and combines engineering, chemistry and biology trends.

2 employees
Biotechnology, Life Sciences
Acoerela vs
NIRvana Sciences
NIRvana Sciences United States

Ultra-Narrow Emission Dyes and Probes

Venture round
8 employees
Biotechnology, Life Sciences

FAQ About Acoerela

Driving Innovation in Optical Probes for Research and Clinical Diagnostics 🌈
Acoerela was founded in 2022.
Acoerela is headquartered in Singapore.
Acoerela operates in Biotechnology and Life Sciences. Its work centres on fluorescent dyes, chemistry, life science research and clinical diagnostics.
Acoerela has approximately 7 employees.
Top alternatives and competitors to Acoerela include Promea Therapeutics, MEDHOM Materials, Biotechnology & Consultancy Services Co. Ltd., NIRvana Sciences, MBL International Corporation, HTG Molecular Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acoerela and Promea Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Acoerela, https://bouncewatch.com/company/acoerela, updated 30 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout